Proton Therapy Dose Characterization and Verification
Abstract
This report describes continued work on the award Neurocognitive Effects of Radiotherapy, which examines the neurocognitive and imaging impact of proton therapy for patients will low grade glioma and base of skull meningioma. A total of 58 patients have been enrolled. All cohort 1 and 2 patients have completed a 4-5 hour neurocognitive testing assessment at baseline by Dr. Carol Armstrong. In addition, cohort patients have completed a 1 hour standard MRI as well as additional testing including diffuse tensor imaging (DTI), perfusion and diffusion. The majority of patients have completed baseline and at least three additional time-points in regards to both neurocognitive testing and MRI. Eighteen patients have completed neurocognitive and imaging evaluation at planned timepoints. Dr. Michelle Alonso-Basanta is Principle Investigator for this. Catherine Feinstein is the Clinical Research Coordinator managing the associated IRB-approved protocol. Dr. Christine Hill-Kayser is the Project Manager for this section of the award. Further budgetary details are outlined in the attached document.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2016
- Accession Number
- AD1031087
Entities
People
- Alexander Lin
- Carol Armstrong
- Christine Hill-kayser
- Harish Poptani
- Lilie Lin
- Manoj Kumar
- Michelle Alonso-basanta
- Peter Gabriel
- Robert Lustig
- Ron Wolf
- Tim Zhu
- Zelig Tochner